D. C. Kahraman Et Al. , "Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib," American Association for Cancer Research Annual Meeting 2018 , vol.78, Chicago, United States Of America, pp.3937, 2018
Kahraman, D. C. Et Al. 2018. Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib. American Association for Cancer Research Annual Meeting 2018 , (Chicago, United States Of America), 3937.
Kahraman, D. C., Kahraman, T., & ATALAY, R., (2018). Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib . American Association for Cancer Research Annual Meeting 2018 (pp.3937). Chicago, United States Of America
Kahraman, DENİZ, Tamer Kahraman, And RENGÜL ATALAY. "Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib," American Association for Cancer Research Annual Meeting 2018, Chicago, United States Of America, 2018
Kahraman, DENİZ C. Et Al. "Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib." American Association for Cancer Research Annual Meeting 2018 , Chicago, United States Of America, pp.3937, 2018
Kahraman, D. C. Kahraman, T. And ATALAY, R. (2018) . "Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib." American Association for Cancer Research Annual Meeting 2018 , Chicago, United States Of America, p.3937.
@conferencepaper{conferencepaper, author={DENİZ CANSEN KAHRAMAN Et Al. }, title={Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib}, congress name={American Association for Cancer Research Annual Meeting 2018}, city={Chicago}, country={United States Of America}, year={2018}, pages={3937} }